Ancestry-Associated Distribution of IL6, IL1B, and TNF Variants Reveals Differential Genetic Susceptibility to Inflammatory Diseases

In the human body, inflammation is a vital defense mechanism, a controlled fire that rises to fight infection and heal wounds. However, when this fire burns too long or too hot without a clear enemy, it can damage healthy tissue and lead to chronic conditions like obesity, heart disease, and metabolic syndrome. The intensity of this inflammatory response is partly written into our DNA. Specific tiny differences in our genetic code, known as single nucleotide variants, act like switches that can turn the volume of inflammation up or down. These switches vary from person to person, and they vary even more between groups of people who have lived in different parts of the world for thousands of years. Understanding these genetic differences is crucial because a risk factor for disease in one population might be harmless in another, meaning that medical advice and research must be tailored to the specific ancestry of the people being studied.

A team of researchers at the Universidad de Guadalajara set out to map these genetic switches within Mexico, a country defined by a rich tapestry of ancestry. Mexico is home to 68 officially recognized Indigenous groups, who make up about 10 percent of the population, while the remaining 90 percent are primarily Mestizos, a population formed by the mixing of European, African, and Indigenous ancestors over the last 500 years. The scientists focused on three specific genes known to influence inflammation: IL6, IL1B, and TNF. They examined the genetic code of 400 samples per genetic variant, drawn from resident unrelated subjects across six different Mestizo regions and four distinct Indigenous communities: the Tarahumaras of the north, the Mayas of the southeast, the Purepechas of the west, and the Nahuas of the center. By using a precise laboratory technique to read the DNA, they counted how often the "risk" versions of these genes appeared in each group.

The results revealed a striking divide between the genetic landscapes of these populations. The researchers found that the distribution of these inflammatory gene variants was not uniform; instead, it varied significantly depending on ancestry. The Indigenous groups, particularly the Tarahumaras, showed a much lower frequency of the genetic variants associated with high inflammatory risk compared to the Mestizo population. In fact, when the researchers combined the three genes to estimate a cumulative genetic risk, 51.2 percent of the Indigenous individuals fell into a "non-risk" category, meaning they carried none of the high-risk variants. In contrast, only 23.8 percent of the Mestizo individuals fell into this same low-risk category. The Mestizo population, which carries a mix of ancestries, showed a genetic profile much closer to that of European populations, where 87.5 percent of individuals were classified in the high-risk category.

This study suggests that the history of a population shapes its biological susceptibility to disease. The Indigenous groups in the study displayed genetic patterns that have likely been preserved through long periods of isolation and distinct evolutionary paths, resulting in a genetic makeup that is less prone to the specific inflammatory risks identified in this research. The Tarahumara group, for instance, was found to be monomorphic for one of the genes, meaning every individual in that group carried the same version of the gene, showing a complete lack of the variant that increases risk. This contrasts with the Mestizo population, whose genetic diversity reflects the complex mixing of different ancestral lines, resulting in a higher prevalence of the risk-associated variants. The researchers noted that these findings highlight a critical gap in current medical understanding: genetic risk is not a universal constant but a variable trait that depends heavily on where a person's ancestors came from.

The implications of these findings extend beyond simple statistics. The study indicates that applying genetic risk models developed primarily in European populations to Mexican Indigenous groups could lead to inaccurate conclusions. A genetic variant that signals high risk in a person of European descent might be rare or absent in an Indigenous person, and vice versa. The researchers emphasized that ignoring these deep ancestral differences could distort our understanding of disease susceptibility and limit the effectiveness of public health strategies. By establishing a clear baseline of how these inflammatory genes are distributed across Mexico's diverse populations, the study provides a necessary foundation for more precise and equitable biomedical research. It serves as a reminder that to truly understand the human body and its vulnerabilities, we must look at the unique genetic stories written in the DNA of every distinct community.